Across TCGA pan-cancer cohorts, DCUN1D2-AS RNA is linked to patient survival in 25 of 34 cancer types, making it the most broadly survival-associated DCUN1D2-AS data layer.
The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher DCUN1D2-AS RNA is associated with worse overall survival. In most high-consensus cancer types, elevated DCUN1D2-AS expression acts as an unfavorable survival marker, although some lineages such as READ and LIHC show a favorable association.
KIRP, COAD, and READ are the cancer types where DCUN1D2-AS RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.